Epigenetic upregulation of CXCL 12 expression mediates antitubulin chemotherapeutics-induced neuropathic pain
Epigenetic upregulation of CXCL 12 expression mediates antitubulin chemotherapeutics-induced neuropathic pain
复制标题
CXCL 12 表达的表观遗传上调介导抗微管蛋白化疗药物诱导的神经性疼痛
DOI:
10.1097/j.pain.0000000000000805
复制
发表时间:
2017-04-01
期刊:
影响因子:
7.4
通讯作者:
Xin, Wen-Jun
中科院分区:
文献类型:
--
作者:
Xu, Ting;Zhang, Xiao-Long;Xin, Wen-Jun
Clinically, Microtubule-targeted agents-induced neuropathic pain hampers chemotherapeutics for patients with cancer. Here, we found that application of paclitaxel or vincristine increased the protein and mRNA expression of CXCL 12 and frequency and amplitude of miniature excitatory post synaptic currents (mEPSCs) in spinal dorsal horn neurons. Spinal local application of CXCL 12 induced the long-term potentiation of nociceptive synaptic transmission and increased the amplitude of mEPSCs. Inhibition of CXCL 12 using the transgenic mice (CXCL 12(-/+)) or neutralizing antibody or siRNA ameliorated the mEPSC's enhancement and mechanical allodynia. In addition, paclitaxel and vincristine both could increase the phosphorylation of signal transducer and activator of transcription 3 (STAT3) and the acetylation of histone H4 in the CXCL 12-expressing neurons. Immunoprecipitation and chromatin immunoprecipitation assays demonstrated that antitubulin chemotherapeutics increased the binding of STAT3 to the CXCL 12 gene promoter and the interaction between STAT3 and p300, and contributed to the enhanced transcription of CXCL 12 by increasing the acetylation of histone H4 in CXCL 12 gene promoter. Inhibition of STAT3 by intrathecal injection of adeno-associated virus encoding Cre and green fluorescent protein into STAT3(flox/flox) mice or inhibitor S3I-201 into rats suppressed the CXCL 12 upsurge by decreasing the acetylation of histone H4. Finally, blockade of CXCR4 but not CXCR7 ameliorated the paclitaxel-or vincristine-induced mechanical allodynia. Together, these results suggested that enhanced interaction between STAT3 and p300 mediated the epigenetic upregulation of CXCL 12 in dorsal horn neurons, which contributed to the antitubulin chemotherapeutics-induced persistent pain.